A scientist at Seraxis looking at the company's pancreatic organoids through a microscope (Credit: Seraxis)
Maryland biotech gets green light for stem cell-derived therapy for diabetes, aiming to compete with Vertex
Stem cell biologist William Rust has been quietly working on a cure for diabetes for more than a decade. Later this year, surgeons will implant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
